Magnetic Resonance Imaging (MRI) As an Outcome Measure in Multiple Sclerosis

1. Paty DW . Magnetic resonance imaging in the assessment of disease activity in multiple sclerosis. Can J Neurol Sci1988;15 (3):266–72.

2. Lee KH , Hashimoto SA , Hooge J , et al. MRI in the diagnosis of MS: a prospective 3 year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurol1991;41:657–60.

3. Li D , Mayo J , Fache S , Robertson WD , Paty D , Genton M . Early experience in nuclear magnetic resonance imaging of multiple sclerosis. Ann NY Acad Sci1984;436:483–86.

4. Stewart WA , Alvord EC , Gruby S , Hall LD , Paty DW . Early detection of experimental allergic encephalomyelitis by magnetic resonance imaging. Lancet1985;2:898.

5. Stewart WA , Hall LD , Berry K , Churg A , Oger J , Hashimoto SA , Paty DW . Magnetic resonance imaging (MRI) in multiple sclerosis (MS): pathological correlation studies in eight cases. Neurol1986;36 (Suppl.1):320.

6. Ormerod IE , Miller DH , McDonald WI , et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. Brain1987;110:1579–1616.

7. Newcombe J , Hawkins CP , Henderson CL , et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain1991;114:1013–23.

8. Davie CA , Hawkins CP , Barker GJ , et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet1993;341:630–31.

9. Wollinsky JS , Narayano PA , Fenstermacher MJ . Proton magnetic resonance spectroscopy in multiple sclerosis. Neurol1990;40:1764–69.

10. Koopmans RA , Li DKB , Zhu G , et al. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products. Lancet1993;341:631–32.

11. Franklin GM , Heaton RK , Nelson LM , Filley CM , Seibert C . Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis. Neurol1988;38(12):1826–29.

12. Kiel MK , Greenspu B , Grossman RI . Magnetic resonance imaging and degree of disability of multiple sclerosis. Arch Phys Med Rehabil1988;69:11.

13. Huber SJ , Paulson GW , Chakeres D , et al. Magnetic resonance imaging and clinical correlations in multiple sclerosis. J Neurol Sci1988;86:1–12.

14. Paty DW , Li DKB , et al. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurol1993;43:662–67.

15. Koopmans RA , Li DK , Grochowski E , Cutler PJ , Paty DW . Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features (1989a). Ann Neurol1989;25(1):74–81.

16. Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurol1983;33:1444–52.

17. Honer WG , Hurwitz T , Li DK , Palmer M , Paty DW . Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol1987;44(2):187–90.

18. Baumhefner RW , Tourtellotte WW , Syndulko K , et al. Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging: its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis. Arch Neurol1990;47(1):19–26.

19. Koopmans RA , Palmer MR , Li DBK , et al. The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis. J Neuroimag1993;3:163–68.

20. The multiple sclerosis study group : efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. Ann Neurol1990;27:591–605.

21. Kappos L , Stadt D , Ratzka M , et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiol1988;30(4):299–302.

22. The IFNB MS Study Group. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology1993;43:665–61.

23. Tanton BL , Paty DW , Li DKB . MRI in determining MS disease activity in a clinical trial. Can J Neurol Sci1990;17(2):219.

24. Johnson MA , Li DK , Bryant DJ , Payne JA . Magnetic resonance imaging: serial observations in multiple sclerosis. AJNR1984;5(5):495–99.

25. Isaac C , Li DK , Genton M , et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology1988;38(10):1511–15.

26. Willoughby EW , Grochowski E , Li DK , Oger J , Kastrukoff LF , Paty DW . Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol1989;25(1):43–49.

27. Koopmans RA , Li DK , Oger JJ , et al. Chronic progressive multiple sclerosis: serial magnetic resonance brain imaging over six months. Ann Neurol1989;26:248–56.

28. Miller DH , Rudge P , Johnson G , et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain1989;111:927–39.

29. Kermode AG , Tofts PS , Thompson AJ , et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology1990;40:229–35.

30. Bastiianello S , Pozzilli C , Bernardi S , Bozzao L , Fantozzi LM , Buttinelli C , Fieschi C . Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis. Neurology1990;40(4):591–95.

31. Wiebe S , Lee DH , Karlik SJ , et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol1992;32:643–50.

32. Harris JO , Frank JA , Patronas N , McFarlin DE , McFarland HF . Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol1991;29:548–55.

33. Thompson AJ , Keromode AG , MacManus DG , et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. Brit Med J1990;300:631–34.

34. Smith ME , Stone LA , Albert PS , et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol1993;33:480–89.

35. Miller DH , Barkhof F , Berry I , et al. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psych1991;54:683–688.

36. Koopmans RA , Li DKB , Oger JJF , Mayo J , Paty DW . The lesion of multiple sclerosis: imaging acute and chronic stages. Neurology1989;39:959–63.